These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19073276)

  • 1. Ligand efficiency and fragment-based drug discovery.
    Bembenek SD; Tounge BA; Reynolds CH
    Drug Discov Today; 2009 Mar; 14(5-6):278-83. PubMed ID: 19073276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two 'Golden Ratio' indices in fragment-based drug discovery.
    Orita M; Ohno K; Niimi T
    Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding efficiency: trends, physical basis, and implications.
    Reynolds CH; Tounge BA; Bembenek SD
    J Med Chem; 2008 Apr; 51(8):2432-8. PubMed ID: 18380424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
    Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
    J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of small molecule inhibitors of protein-protein interactions using combined ligand and target score normalization.
    Casey FP; Pihan E; Shields DC
    J Chem Inf Model; 2009 Dec; 49(12):2708-17. PubMed ID: 19994847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead generation and examples opinion regarding how to follow up hits.
    Orita M; Ohno K; Warizaya M; Amano Y; Niimi T
    Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
    Barelier S; Krimm I
    Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
    Reitz AB; Smith GR; Tounge BA; Reynolds CH
    Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
    Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
    Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL
    Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and implementation of an ribonucleic acid (RNA) directed fragment library.
    Bodoor K; Boyapati V; Gopu V; Boisdore M; Allam K; Miller J; Treleaven WD; Weldeghiorghis T; Aboul-ela F
    J Med Chem; 2009 Jun; 52(12):3753-61. PubMed ID: 19445516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing fragment-based inhibitor discovery.
    Babaoglu K; Shoichet BK
    Nat Chem Biol; 2006 Dec; 2(12):720-3. PubMed ID: 17072304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to fragment-based drug discovery.
    Erlanson DA
    Top Curr Chem; 2012; 317():1-32. PubMed ID: 21695633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.